awmsg logo



fludrocortisone acetate (not known)


Reference No. 3482

Publication date:
26/05/2017


Appraisal information

fludrocortisone acetate (not known) 0.1 mg tablet


Company: Aspen
BNF category: Endocrine system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 25/05/2017

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, fludrocortisone acetate cannot be endorsed for use within NHS Wales as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome.
Statement of Advice (SOA)
Download